SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-21-000171
Filing Date
2021-11-12
Accepted
2021-11-12 17:01:44
Documents
75
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q scps-20210930x10q.htm   iXBRL 10-Q 1372296
2 EXHIBIT 31.1 scps-20210930xex31d1.htm EX-31.1 12610
3 EXHIBIT 31.2 scps-20210930xex31d2.htm EX-31.2 13485
4 EXHIBIT 32.1 scps-20210930xex32d1.htm EX-32.1 5797
5 EXHIBIT 32.2 scps-20210930xex32d2.htm EX-32.2 5757
  Complete submission text file 0001410578-21-000171.txt   5728294

Data Files

Seq Description Document Type Size
6 EX-101.SCH scps-20210930.xsd EX-101.SCH 60160
7 EX-101.CAL scps-20210930_cal.xml EX-101.CAL 32699
8 EX-101.DEF scps-20210930_def.xml EX-101.DEF 205516
9 EX-101.LAB scps-20210930_lab.xml EX-101.LAB 439417
10 EX-101.PRE scps-20210930_pre.xml EX-101.PRE 357307
11 EXTRACTED XBRL INSTANCE DOCUMENT scps-20210930x10q_htm.xml XML 751843
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39788 | Film No.: 211404631
SIC: 2834 Pharmaceutical Preparations